Generated by All in One SEO v4.9.7.2, this is an llms.txt file, used by LLMs to index the site.

# Avigen

Accelerating Immunotherapy Development

## Sitemaps

- [XML Sitemap](https://avigen.bio/sitemap.xml): Contains all public & indexable URLs for this website.

## Posts

- [Avigen and Etcembly Complete Collaboration Evaluating AI-Designed Multi-specific Cell Engagers](https://avigen.bio/etcembly/) - London, UK – 12 March 2026 – Avigen Ltd (“the Company”), a privately held Contract Research Organisation developing advanced preclinical immunotherapy R&D services using its proprietary microfluidic platform and Etcembly Ltd, a techbio company leveraging generative AI for the development of novel biologics, today announced the successful completion of a collaborative study focused on the
- [Avigen Strengthens Growth Trajectory Through Royal Academy of Engineering Enterprise Fellowship Award](https://avigen.bio/avigen-strengthens-growth-trajectory-through-royal-academy-of-engineering-enterprise-fellowship-award/) - London, UK – 1 January 2026 – Avigen Ltd (“the Company”), a privately held Contract Research Organisation developing advanced preclinical immunotherapy R&D services using its proprietary microfluidic platform, today announced that Neelima KC, Founder of Avigen Ltd. has been awarded a prestigious Royal Academy of Engineering Enterprise Fellowship. Delivered through the Royal Academy of Engineering’s
- [Avigen Raises £300k from SFC Capital to Launch CRO Services](https://avigen.bio/seed-funding/) - Avigen Raises £300k from SFC Capital to Launch Immunotherapy CRO Services London, UK – 31 March 2025 – Avigen (“the Company”), a privately held Contract Research Organisation spun out from Imperial College London developing advanced preclinical immunotherapy R&D services using its proprietary microfluidic platform, today announced the successful close of a £300,000 seed funding round
- [Avigen Selected to Participate in the DeepTech Catalyst Biotech Incubator Programme](https://avigen.bio/deep-tech-catalyst/) - Avigen Awarded £300K Grant to Accelerate Cell Therapy R&D Innovation London, UK – 11 February 2026 – Avigen Ltd (“the Company”), a privately held Contract Research Organisation developing advanced preclinical immunotherapy R&D services using its proprietary microfluidic platform, today announced its participation in the DeepTech Catalyst Biotech Incubator (DTC Bio) programme, formerly known as the
- [Avigen enters Collaboration with NK:IO to Advance NK Cell Therapies for Solid Tumours](https://avigen.bio/nkio-collaboration/) - London, UK – 12 September 2025 – Avigen Ltd (“the Company”), a privately held Contract Research Organisation developing advanced preclinical immunotherapy R&D services using its proprietary microfluidic platform, today announced a preclinical research and development (R&D) collaboration with NK:IO, a biotechnology company pioneering natural killer (NK) cell-based therapies for haematological and solid tumours. This collaboration
- [Avigen Joins the White City Incubator](https://avigen.bio/white-city-incubator/) - Avigen Joins the White City Incubator We are excited to announce that Avigen has moved into the White City Incubator, marking an exciting new chapter for our company as we continue to develop and scale our platform and associated service offerings. Located in the heart of the White City Innovation District, this world-class facility provides
- [Avigen Awarded £300K Grant to Accelerate Cell Therapy R&D Innovation](https://avigen.bio/icure/) - Avigen Awarded £300K Grant to Accelerate Cell Therapy R&D Innovation London, UK – 1 April 2025 – Avigen (“the Company”), a privately held Contract Research Organisation spun out from Imperial College London developing advanced preclinical immunotherapy R&D services using its proprietary microfluidic platform, today announced that it has been awarded a £300,000 Innovate UK Innovation-to-Commercialisation

## Pages

- [Home](https://avigen.bio/) - Avigen provides analytical immunotherapy and cell therapy R&D services using avidity to identify potent and safe lead drug candidates faster.
- [About us](https://avigen.bio/about/) - aboutAvigen is a Contract Research Organisation, spun out from Imperial College London. At Avigen, we are developing the next generation of preclinical research and development services for immunotherapies, using our proprietary microfluidic platform. By assessing cellular avidity at high-throughput, we rapidly identify, sort, and isolate the most therapeutically valuable, target-specific cells from a broad pool
- [Technology](https://avigen.bio/technology/) - A new dimension in immune cell selection Our platform is capable of assessing cellular avidity, the total binding strength between immune and target cells, to precisely identify and select the most potent immunotherapy candidates.By uniting robust characterisation with high-throughput sorting and isolation of viable cells, the platform accelerates lead discovery and streamlines R&D workflows. Scientists
- [Contact us](https://avigen.bio/contact/) - get in touchWant to work with us? Get in touch, we would love to hear from you. Interested in working together or collaborating? We partner with biotech and pharma focused on immunotherapies for solid tumours. Our Location 58 Wood Lane, Scale Space,W12 7RZ, London, UK Email info@avigen.bio Social media LinkedIn Please enable JavaScript in your
- [Service page](https://avigen.bio/service-page/) - We accelerate and de-risk your preclinical development We measure what truly matters - cellular avidity - helping you uncover the next blockbuster therapies in your pipeline, faster and with confidence. Learn more Learn more We accelerate and de-risk your preclinical development We measure what truly matters - cellular avidity - helping you uncover the next
- [Case studies](https://avigen.bio/case-studies-page/) - CARCAR-iNKTSolid tumourAvidity-based CAR-iNKT target engagement and in-vivo efficacy prediction​ Solid tumourT cellsTCR T CellsAvidity-based detection, sorting and isolation of TCR T cells AntibodiesCell engagerSolid tumourT cellsAssessment of cell engager-mediated T cell target engagement and function ADCCNK cellsSolid tumourAvidity assessment of cetuximab-mediated NK cell target engagement and function
- [Samples](https://avigen.bio/samples-intake/) - Please enable JavaScript in your browser to complete this form.Please enable JavaScript in your browser to complete this form.Your DetailsName *FirstLastCompany or Institution *Email Address *🧬 Effector Cell Information01Cell IdentitySample Name / IDPassage NumberSourceNumber of VialsCells per VialHas this cell been engineered?YesNoTherapeutic Target(s)Complete if cell has been engineeredEngineering Method— Select —Lentiviral VectorRetroviral VectorElectroporation / mRNACRISPR/Cas9Transposon
- [Brochure](https://avigen.bio/brochure/) - Download our service brochure Please enable JavaScript in your browser to complete this form.Please enable JavaScript in your browser to complete this form.Name *FirstLastEmail *Organisation *Job Title *- Select -Academic ResearcherBusiness DevelopmentIndustry Research ScientistInnovation or Partnership LeadLab Technican or StaffOtherIndustry *- Select -AcademiaBiotechnologyCRO / CDMO / CRDMOPharmaceuticalOtherPlease specify *Please specify *Subscribe to newsletterI would like
- [Company and Science news](https://avigen.bio/news/) - March 12, 2026Avigen and Etcembly Complete Collaboration Evaluating AI-Designed Multi-specific Cell EngagersPress ReleaseLearn more February 11, 2026Avigen Selected to Participate in the DeepTech Catalyst Biotech Incubator ProgrammePress ReleaseLearn more January 12, 2026Avigen Strengthens Growth Trajectory Through Royal Academy of Engineering Enterprise Fellowship AwardPress ReleaseLearn more September 12, 2025Avigen enters Collaboration with NK:IO to Advance NK
- [test](https://avigen.bio/test/)
- [Partnering and Collaborations](https://avigen.bio/partnering/) - Partnerships are at our core Partnerships and collaborations are integral to Avigen’s mission of accelerating the development of immunotherapies and biologics to cure cancer. We form mutually beneficial relationships with global industry partners and academic institutions to enhance our capabilities and unlock the full potential of cellular therapies. Call for pilot study partners Avigen is actively

## My Templates

- [correct width template](https://avigen.bio/?elementor_library=correct-width-template) - our proprietary technologyA new dimension in immunotherapy R&D Our platform redefines how potent immune cells are identified—measuring cellular avidity to uncover what truly drives therapeutic success. Physiological Relevance Captures the full complexity of live immune–target cell interactions, delivering insights that better reflect in-vivo therapeutic behaviour. High Throughput Analyses tens of thousands of single-cell interactions per
- [Technology](https://avigen.bio/?elementor_library=technology) - A new dimension in immune cell selection Our platform is capable of assessing cellular avidity, the total binding strength between immune and target cells, to precisely identify and select the most potent immunotherapy candidates.By uniting robust characterisation with high-throughput sorting and isolation of viable cells, the platform accelerates lead discovery and streamlines R&D workflows. Scientists
- [contact page full width](https://avigen.bio/?elementor_library=contact-page-full-width) - get in touchWant to work with us? Get in touch, we would love to hear from you. Interested in working together or collaborating? We partner with biotech and pharma focused on immunotherapies for solid tumours. Our Location 58 Wood Lane, Scale Space,W12 7RZ, London, UK Email info@avigen.bio Social media LinkedIn Please enable JavaScript in your
- [full width contact block](https://avigen.bio/?elementor_library=full-width-contact-block) - get in touchWant to work with us? Get in touch, we would love to hear from you. Interested in working together or collaborating? We partner with biotech and pharma focused on immunotherapies for solid tumours. Our Location 58 Wood Lane, Scale Space,W12 7RZ, London, UK Email info@avigen.bio Social media LinkedIn Please enable JavaScript in your
- [home technology](https://avigen.bio/?elementor_library=home-technology) - Watch video Watch video Wellestablished Realized projects 0 K+ Active users every day 0 + Neuro AI aboutWelcome to new era of Neural networks Artificial Intelligence refers to the development of computer systems that can perform tasks that would typically require human intelligence. It involves the creation of algorithms and models that enable machines to
- [block with button](https://avigen.bio/?elementor_library=block-with-button) - Discover our services
- [brochure block mobile](https://avigen.bio/?elementor_library=brochure-block-mobile-2) - Learn more about our capabilities Download our brochure to explore Avigen’s capabilities and services supporting biotech, pharma, and research teams. Download our Brochure
- [borchure block big screen](https://avigen.bio/?elementor_library=borchure-block-big-screen) - Learn more about our capabilities Download our brochure to explore Avigen’s capabilities and services supporting biotech, pharma, and research teams. Download our Brochure
- [brochure block mobile](https://avigen.bio/?elementor_library=brochure-block-mobile) - Learn more about our capabilities Download our brochure to explore Avigen’s capabilities and services supporting biotech, pharma, and research teams. Download our Brochure
- [brochure block](https://avigen.bio/?elementor_library=brochure-block) - Discover what we can do for you Download our brochure to explore Avigen’s capabilities and services supporting biotech, pharma, and research teams. Download
- [Default Kit](https://avigen.bio/?elementor_library=default-kit)
- [blue box](https://avigen.bio/?elementor_library=blue-box) - Need additional data and assays to validate your immunotherapy? We are here to help you take your immunotherapy to the next level. Get in touch with us, and together we will explore custom solutions tailored to your unique needs. Our team is dedicated to providing the insights that will ensure your therapy’s success. Let us
- [services](https://avigen.bio/?elementor_library=services) - ValidationImmunotherapy validation DiscoveryImmunotherapy discovery
- [Service page top](https://avigen.bio/?elementor_library=service-page-top) - Discover future business with AI Neuro consultingConvert text to natural-sounding speech. Customizable, multilingual, and high-quality audio output.Discover Watch video Watch video 0 + Creative specialist in our team Generated over $50 million in additional revenue for our clients.Convert text to natural-sounding speech. Customizable, multilingual, and high-quality audio output.Discover Watch video Watch video 0 + Creative
- [video block middle](https://avigen.bio/?elementor_library=video-block-middle) - Watch video Watch video
- [top section about us](https://avigen.bio/?elementor_library=top-section-about-us) - aboutAvigen is a next-generation Contract Research Organisation, spun out from Imperial College London. At Avigen, we are developing the next generation of preclinical research and development services for cellular immunotherapies targeting solid tumours, using our proprietary microfluidic platform. By assessing cellular avidity at high-throughput, we rapidly identify, sort, and isolate the most therapeutically valuable, target-specific
- [3 large fields with buttons below each other](https://avigen.bio/?elementor_library=3-large-fields-with-buttons-below-each-other) - Robotic Process Automation (RPA) A neural network consists of interconnected nodes called neurons. Neurons are organized into layers.
- [contact form and address](https://avigen.bio/?elementor_library=contact-form-and-address) - get in touchWant to learn more? Get in touch, we would love to hear from you. Interested in learning more, collaborating, or sharing ideas? We’re eager to partner with biotech and pharma focused on cellular immunotherapies for solid tumours. Our Location Scale Space White City58 Wood Lane, London W12 7RZ Email info@avigen.bio Social networks Linkedin-in
- [supporters](https://avigen.bio/?elementor_library=supporters) - partnersWe are proudly supported by
- [three boxes expandable next to each other](https://avigen.bio/?elementor_library=three-boxes-expandable-next-to-each-other) - featuresInnovative features of our AI solutions Robotic Process Automation (RPA) Data Analysis and Visualization Insightful market research for strategic business decisions Robotic Process Automation (RPA) Artificial Intelligence refers to the development of computer systems that can perform tasks that would typically require human intelligence. It involves the creation of algorithms and models that enable machines
- [three blocks in line next to each other](https://avigen.bio/?elementor_library=three-blocks-in-line-next-to-each-other) - Robotic Process Automation (RPA) Data Analysis and Visualization Insightful market research for strategic business decisions
- [three blocks](https://avigen.bio/?elementor_library=three-blocks) - Neuro AI aboutWelcome to new era of Neural networks Artificial Intelligence refers to the development of computer systems that can perform tasks that would typically require human intelligence. It involves the creation of algorithms and models that enable machines to learn, reason, perceive, and make decisions.There are generally two types of AI: Narrow or Weak
- [block with text glass morphism](https://avigen.bio/?elementor_library=block-with-text-glass-morphism) - 2,000 companies use Neuro to power their integrations
- [contact with contact form](https://avigen.bio/?elementor_library=contact-with-contact-form) - get in touchWant to learn more? Get in touch, we would love to hear from you. Interested in learning more, collaborating, or sharing ideas? We’re eager to partner with biotech and pharma focused on cellular immunotherapies for solid tumours. Our Location Scale Space White City58 Wood Lane, London W12 7RZ Email info@avigen.bio Social networks Linkedin-in
- [Contact address email etc](https://avigen.bio/?elementor_library=contact-address-email-etc) - Our Location Scale Space White City58 Wood Lane, London W12 7RZ Email info@avigen.bio
- [three blocks and video](https://avigen.bio/?elementor_library=three-blocks-and-video) - Machine LearningSolutions Develop and deploy custom machine learning models to extract insights and make predictions from your data. Watch video Watch video Natural Language Processing Active users every day 0 + Powered by
- [Blocks with download button](https://avigen.bio/?elementor_library=blocks-with-download-button) - Custom synthesis Synthesis of specialized compounds and reagents Tailored solutions for specific research needs Advanced data analysis services Comprehensive interpretation and reporting of results Download PDF Prototyping and scale-Up Development of prototypes for new products Scale-up services for commercial production Hands-on training for laboratory techniques and instrumentation Workshops on emerging technologies and methodologies Download PDF
- [image with list and image change per list](https://avigen.bio/?elementor_library=image-with-list-and-image-change-per-list) - how it worksHow to generate AI speech with Neuro 01. Generate voice for you videoA neural network consists of interconnected nodes called neurons. Neurons are organized into layers. 02. Clone voiceEach neuron applies an activation function to the weighted sum of its inputs and produces an output 03.Download ready filesThe inputs are multiplied by their
- [video block](https://avigen.bio/?elementor_library=video-block) - Watch video Watch video
- [case study block dark](https://avigen.bio/?elementor_library=case-study-block-dark) - case studyTransformative AI Solutions in action July / 2430ADCCNK cellsSolid tumourAvidity assessment of cetuximab-mediated NK cell target engagement and functionExplore more April / 2610AntibodiesCell engagerSolid tumourT cellsAssessment of cell engager-mediated T cell target engagement and functionExplore more Explore more
- [three equal blocks clean about](https://avigen.bio/?elementor_library=three-equal-blocks-clean-about) - Neuro AI aboutWelcome to new era of Neural networks Artificial Intelligence refers to the development of computer systems that can perform tasks that would typically require human intelligence. It involves the creation of algorithms and models that enable machines to learn, reason, perceive, and make decisions.There are generally two types of AI: Narrow or Weak
- [counting numbers](https://avigen.bio/?elementor_library=counting-numbers) - achievementsRemarkable achievements and milestones $ 0 million Revenue Growth Generated over $50 million in additional revenue for our clients 0 % Client Satisfaction 98% client satisfaction rate across all marketing campaigns. 0 + Conversion Rate Successfully managed and executed 1,000+ marketing campaigns.
- [large text with gradient](https://avigen.bio/?elementor_library=large-text-with-gradient) - Empowering Businesses with AI-driven marketing solutions to boost engagement, drive conversions and unlock new levels of growth and success.
- [Blocks white and black with button](https://avigen.bio/?elementor_library=blocks-white-and-black-with-button) - Optimize your campaigns with ad performance analysis Insightful market research for strategic business decisions $ 0 mil Cost savings for our customers
- [Dark section multiple](https://avigen.bio/?elementor_library=dark-section-multiple) - aboutWelcome to new era of Neural networks Neuro AI Artificial Intelligence refers to the development of computer systems that can perform tasks that would typically require human intelligence. It involves the creation of algorithms and models that enable machines to learn, reason, perceive, and make decisions.There are generally two types of AI: Narrow or Weak
- [customer opinion quote](https://avigen.bio/?elementor_library=customer-opinion-quote) - Working withNeuro has been a game-changer for our business. Their AI solutions have revolutionized our operations, enabling us to automate repetitive tasks and make data-driven decisions with ease. We couldn't be happier with the results."John AndersonCEO of XYZ CompanyWorking withNeuro has been a game-changer for our business. Their AI solutions have revolutionized our operations, enabling
- [setp by step scrollable](https://avigen.bio/?elementor_library=setp-by-step-scrollable) - how it worksNeural networks are a fundamental component of Artificial Intelligence (AI) systems 01Neurons and LayersA neural network consists of interconnected nodes called neurons. Neurons are organized into layers.02Activation FunctionEach neuron applies an activation function to the weighted sum of its inputs and produces an output03Feedforward ProcessThe inputs are multiplied by their respective weights, summed
- [Block with video and checkpoint list next to it](https://avigen.bio/?elementor_library=block-with-video-and-checkpoint-list-next-to-it) - Watch video Watch video featuresHow to work with chatbot Neuro Natural Language Processing (NLP) AI chatbots use NLP algorithms to understand and interpret user input, enabling them to respond in a human-like manner and handle complex queries. User Intent Recognition AI chatbots can identify the intent behind user queries, enabling them to provide relevant answers
- [Newsletter email insert](https://avigen.bio/?elementor_library=newsletter-email-insert) - Subscribe for latest updates & insights Pacific hake false trevally queen parrotfish black prickleback mosshead warbonnet sweeper! Greenling sleeper. SubscribeLeave this field empty if you're human:
- [Block with company logos and text](https://avigen.bio/?elementor_library=block-with-company-logos-and-text) - 2,000 companies use Neuro to power their integrations AtlassianThere are generally two types of AI: Narrow or Weak AI, which is designed to perform specific tasks WindowsWhich possesses human-level intelligence and can handle a wide range of tasks. MicrosoftWhich possesses human-level intelligence and can handle a wide range of tasks. Intel CorpPossesses human-level intelligence and
- [Blog](https://avigen.bio/?elementor_library=blog) - March 12, 2026Avigen and Etcembly Complete Collaboration Evaluating AI-Designed Multi-specific Cell EngagersPress Release February 11, 2026Avigen Selected to Participate in the DeepTech Catalyst Biotech Incubator ProgrammePress Release January 12, 2026Avigen Strengthens Growth Trajectory Through Royal Academy of Engineering Enterprise Fellowship AwardPress Release September 12, 2025Avigen enters Collaboration with NK:IO to Advance NK Cell Therapies for
- [Test Gallery](https://avigen.bio/?elementor_library=test-gallery-2)
- [Default Kit](https://avigen.bio/?elementor_library=default-kit-3)
- [tabs iconbox](https://avigen.bio/?elementor_library=tabs-iconbox-2)
- [footer-form](https://avigen.bio/?elementor_library=footer-form-2) - Pacific hake false trevally queen parrotfish black prickleback mosshead warbonnet sweeper! Greenling sleeper. 800 100 975 20 34+ (123) 1800-234-5678 800 100 975 20 34+ (123) 1800-234-5678 USA, New York – 1060Str. First Avenue 1 neuros@mail.co neuros@mail.co Facebook-f X-twitter Linkedin-in Youtube
- [Test Gallery](https://avigen.bio/?elementor_library=test-gallery)
- [Default Kit](https://avigen.bio/?elementor_library=default-kit-2)
- [tabs iconbox](https://avigen.bio/?elementor_library=tabs-iconbox)
- [footer-form](https://avigen.bio/?elementor_library=footer-form) - Pacific hake false trevally queen parrotfish black prickleback mosshead warbonnet sweeper! Greenling sleeper. 800 100 975 20 34+ (123) 1800-234-5678 800 100 975 20 34+ (123) 1800-234-5678 USA, New York – 1060Str. First Avenue 1 neuros@mail.co neuros@mail.co Facebook-f X-twitter Linkedin-in Youtube
- [Test Gallery](https://avigen.bio/?elementor_library=test-gallery-3) - Architecture Architecture Architecture
- [Test Row](https://avigen.bio/?elementor_library=test-row) - Watch video Watch video
- [footer-form](https://avigen.bio/?elementor_library=footer-form-3) - get in touchWe are always ready to help you and answer your questions Pacific hake false trevally queen parrotfish black prickleback mosshead warbonnet sweeper! Greenling sleeper. Call Center 800 100 975 20 34+ (123) 1800-234-5678 Our Location 800 100 975 20 34+ (123) 1800-234-5678 USA, New York – 1060Str. First Avenue 1 Email neuros@mail.co Social
- [tabs iconbox](https://avigen.bio/?elementor_library=tabs-iconbox-3) - Robotic Process Automation (RPA) Data Analysis and Visualization Insightful market research for strategic business decisions
- [tabs iconbox](https://avigen.bio/?elementor_library=tabs-iconbox-4) - Robotic Process Automation (RPA) Data Analysis and Visualization Insightful market research for strategic business decisions
- [Default Kit](https://avigen.bio/?elementor_library=default-kit-4)
- [Default Kit](https://avigen.bio/?elementor_library=default-kit-5)

## Projects

- [VoxAI: Empowering Communication with AI Voice Generation](https://avigen.bio/projects/voxai-empowering-communication-with-ai-voice-generation/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [Speechify: Your Personal AI Voice Generator Companion](https://avigen.bio/projects/speechify-your-personal-ai-voice-generator-companion/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [Voicemate: Customizable AI Voice for Every Message](https://avigen.bio/projects/voicemate-customizable-ai-voice-for-every-message/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [HealthCareAI: Personalized diagnostics and treatment recommendations with Neural Networks](https://avigen.bio/projects/healthcareai-personalized-diagnostics-and-treatment-recommendations-with-neural-networks/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [AutoDrive: Autonomous vehicle navigation with advanced Neural Networks](https://avigen.bio/projects/autodrive-autonomous-vehicle-navigation-with-advanced-neural-networks/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [Smart Assist](https://avigen.bio/projects/smart-assist-2/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [Smart Assist](https://avigen.bio/projects/smart-assist/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [Smart HomeX](https://avigen.bio/projects/smart-homex/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [Secure Shield](https://avigen.bio/projects/secure-shield/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [Health CareIQ](https://avigen.bio/projects/health-careiq/) - Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake false trevally queen parrotfish black Prickleback moss revally queen parrotfish black
- [DeepVision: Enhancing image recognition with Neural Networks](https://avigen.bio/projects/deepvision-enhancing-image-recognition-with-neural-networks-2/) - Neural networks are a fundamental component of Artificial Intelligence (AI) systems Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake
- [DeepVision: Enhancing image recognition with Neural Networks](https://avigen.bio/projects/deepvision-enhancing-image-recognition-with-neural-networks/) - Neural networks are a fundamental component of Artificial Intelligence (AI) systems Integrating neural network models into existing systems or software applications, enabling businesses to leverage AI capabilities seamlessly. In today's fast-paced and data-driven world, businesses are constantly seeking innovative ways to gain a competitive edge, make smarter decisions, and deliver exceptional customer experiences. Pacific hake

## Team Members

- [Dr Andrew Fadden](https://avigen.bio/team/andrew-fadden/)
- [Dr Neelima KC](https://avigen.bio/team/neelima-kc/)
- [Dr Sam Au](https://avigen.bio/team/dr-sam-au/)
- [Tobias Gamper](https://avigen.bio/team/tobias-gamper/)

## Careers

- [Temporary Laboratory Technician](https://avigen.bio/careers/lab-technician/) - Temporary role (July–December 2025) supporting lab-based R&D of contract research services.

## Services

- [Immunotherapy discovery](https://avigen.bio/services/discovery/) - AI image generators can synthesize new, unique images from scratch and providing best silutions.
- [Immunotherapy validation](https://avigen.bio/services/validation/) - AI image generators can synthesize new, unique images from scratch and providing best silutions.

## Case Studies

- [Avidity-based CAR-iNKT target engagement and in-vivo efficacy prediction​](https://avigen.bio/case-study-archive/car-inkt/) - Discover how avidity-driven functional profiling enables accurate prediction of CAR-iNKT therapy performance before animal studies. Using a dynamic, physiologically relevant platform, CAR-iNKT constructs were quantitatively ranked based on tumour engagement strength, with avidity profiles directly correlating with in vivo tumour control and survival outcomes. High-avidity cell fractions demonstrated significantly enhanced CAR surface expression and functional quality, highlighting a clear link between avidity and therapeutic efficacy. This approach overcomes the limitations of conventional static in vitro assays by providing mechanistic, predictive insight into immune–tumour interactions. By enabling early, cost-efficient identification of high-performing CAR constructs, avidity-based profiling supports faster, safer, and more reliable development of next-generation cell-based immunotherapies while reducing reliance on animal models.
- [Assessment of cell engager-mediated T cell target engagement and function](https://avigen.bio/case-study-archive/etcembly/) - Discover how Avigen's avidity-based microfluidic platform resolved inconclusive cytotoxicity data for Etcembly's novel tri-specific and bi-specific T cell engagers, delivering mechanism-of-action insights and a clear, rank-ordered comparison of cell engager performance against melanoma targets that standard endpoint assays could not provide. Download the full case study to learn how paired avidity and functional data enables confident, de-risked cell engager selection for immunotherapy development.
- [Avidity assessment of cetuximab-mediated NK cell target engagement and function](https://avigen.bio/case-study-archive/nkio/) - Discover how Avigen's avidity-based microfluidic platform resolved inconsistent cytotoxicity data for NK:IO's Cetuximab-mediated NK cell programme, revealing CD16-dependent target engagement and donor-specific avidity differences that standard endpoint assays could not detect. Download the full case study to learn how paired avidity and functional data identified the optimal NK cell population for Cetuximab-driven ADCC, delivering mechanistic clarity that conventional cytotoxicity assays routinely miss.
- [Avidity-based detection, sorting and isolation of TCR T cells](https://avigen.bio/case-study-archive/tcr-t/) - Discover how Avigen's avidity-based platform accurately detects, sorts and isolates high-performing TCR T cells, revealing that avidity reliably predicts cytotoxic killing and T cell activation — delivering mechanistic insight that conventional cytotoxicity assays cannot provide. Download the full case study to learn how our approach enables faster, de-risked TCR T cell candidate selection for immunotherapy development.

## King Addons Templates

- [Discounted rates](https://avigen.bio/?king_addons_ext_pb=user-popup-discounted-rates)

## Categories

- [Press Release](https://avigen.bio/category/press-releases/)
- [Company News](https://avigen.bio/category/company-news/)

## Tags

- [Press release](https://avigen.bio/tag/press-release/)
- [Company News](https://avigen.bio/tag/company-news/)

## Project Categories

- [Audio](https://avigen.bio/neuros_project_category/audio/)
- [Development](https://avigen.bio/neuros_project_category/development/)
- [Modern](https://avigen.bio/neuros_project_category/modern/)

## Service Categories

- [Science](https://avigen.bio/neuros_services_category/science/)

## Case Study Tags

- [NK cells](https://avigen.bio/case-study-tag/nk-cells/)
- [ADCC](https://avigen.bio/case-study-tag/adcc/)
- [Solid tumour](https://avigen.bio/case-study-tag/solid-tumour/)
- [T cells](https://avigen.bio/case-study-tag/t-cells/)
- [Cell engager](https://avigen.bio/case-study-tag/cell-engager/)
- [Antibodies](https://avigen.bio/case-study-tag/antibodies/)
- [TCR T Cells](https://avigen.bio/case-study-tag/tcr-t-cells/)
- [CAR-iNKT](https://avigen.bio/case-study-tag/car-inkt/)
- [CAR](https://avigen.bio/case-study-tag/car/)